Clinical Research Directory
Browse clinical research sites, groups, and studies.
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Sponsor: AstraZeneca
Summary
Purpose of this study is to assess the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of volrustomig in combination with other anticancer drugs in participants with specified solid tumors.
Official title: A Phase II, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Volrustomig Priming Regimens in Combination With Other Anticancer Agents in Participants With Solid Tumors (eVOLVE-01)
Key Details
Gender
All
Age Range
18 Years - 130 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2024-08-27
Completion Date
2027-07-30
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
Volrustomig
Participants will receive volrustomig via intravenous (IV) infusion.
Carboplatin
Participants will receive carboplatin via IV infusion.
Pemetrexed
Participants will receive pemetrexed via IV infusion.
Ramucirumab
Participants will receive ramucirumab via IV infusion.
Paclitaxel
Participants will receive paclitaxel via IV infusion.
Locations (77)
Research Site
Los Angeles, California, United States
Research Site
Grand Junction, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
Research Site
Baltimore, Maryland, United States
Research Site
Detroit, Michigan, United States
Research Site
Chapel Hill, North Carolina, United States
Research Site
Tacoma, Washington, United States
Research Site
Montreal, Quebec, Canada
Research Site
Beijing, China
Research Site
Hangzhou, China
Research Site
Jinan, China
Research Site
Yantai, China
Research Site
Zhengzhou, China
Research Site
Bois-Guillaume, France
Research Site
Caen, France
Research Site
Créteil, France
Research Site
Dijon, France
Research Site
Montpellier, France
Research Site
Batumi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Athens, Greece
Research Site
Athens, Greece
Research Site
Elaiones, Greece
Research Site
Piraeus, Greece
Research Site
Thessaloniki, Greece
Research Site
Genoa, Italy
Research Site
Meldola, Italy
Research Site
Milan, Italy
Research Site
Naples, Italy
Research Site
Orbassano, Italy
Research Site
Perugia, Italy
Research Site
Rozzano, Italy
Research Site
Udine, Italy
Research Site
Verona, Italy
Research Site
Kuala Lumpur, Malaysia
Research Site
Kuching, Malaysia
Research Site
Perai, Malaysia
Research Site
Lisbon, Portugal
Research Site
Lisbon, Portugal
Research Site
Lisbon, Portugal
Research Site
Lisbon, Portugal
Research Site
Porto, Portugal
Research Site
Porto, Portugal
Research Site
Cluj-Napoca, Romania
Research Site
Craiova, Romania
Research Site
Floreşti, Romania
Research Site
Belgrade, Serbia
Research Site
Belgrade, Serbia
Research Site
Kamenitz, Serbia
Research Site
Kragujevac, Serbia
Research Site
Seongnam, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Suwon, South Korea
Research Site
A Coruña, Spain
Research Site
Alcorcón, Spain
Research Site
Barcelona, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain
Research Site
Pamplona, Spain
Research Site
Santander, Spain
Research Site
Santiago de Compostela, Spain
Research Site
Valencia, Spain
Research Site
Valencia, Spain
Research Site
Basel, Switzerland
Research Site
Geneva, Switzerland
Research Site
Lausanne, Switzerland
Research Site
Winterthur, Switzerland
Research Site
Zurich, Switzerland
Research Site
Changhua, Taiwan
Research Site
New Taipei City, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taipei, Taiwan